GATA4 inhibits cell differentiation and proliferation in pancreatic cancer

PLoS One. 2018 Aug 24;13(8):e0202449. doi: 10.1371/journal.pone.0202449. eCollection 2018.

Abstract

Pancreatic ductal carcinoma (PDAC) is a common malignant tumor of the digestive system. GATA4 is one of the transcriptional regulatory factors, which regulates the development of endoderm-derived organs, including heart and gut. GATA4 may act as a putative tumor suppressor gene. However, the role of GATA4 in pancreatic carcinogenesis is not yet clarified. This study showed that GATA4 was highly expressed in pancreatic cancer tissues, and its expression level was positively related to the grade of pathological differentiation, suggesting that it may contribute to the progression of pancreatic neoplasia. Ectopic expression of GATA4 gene reduced cell viability and interference of GATA4 expression significantly increased the colony formation ability of pancreatic cancer cells. Furthermore, GATA4 inhibited tumor growth in xenograft mice. Agilent expression microarray profiling analysis indicated that the genes with significant levels of differential expression in GATA4 over-expressing cells were enriched in the cell differentiation process. Analysis of KEGG signaling pathway demonstrated that the regulated genes were partially enriched in MAPK and JAK-STAT signaling pathways. Re-expression of GATA4 up-regulated P53 gene expression. Our data indicate that GATA4 gene might play a role in cell proliferation and differentiation during the progression of pancreatic cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation*
  • Cell Line, Tumor
  • Cell Proliferation*
  • GATA4 Transcription Factor / biosynthesis*
  • GATA4 Transcription Factor / genetics
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • MAP Kinase Signaling System*
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / genetics
  • Pancreatic Neoplasms / genetics
  • Pancreatic Neoplasms / metabolism*
  • Pancreatic Neoplasms / pathology

Substances

  • GATA4 Transcription Factor
  • GATA4 protein, human
  • Neoplasm Proteins

Grants and funding

This work was supported by grants from the China National Science Foundation (No. 81201957) to YG and the Joint Project of the National Natural Science Foundation of China and the Australian National Health and Medical Research Council (No. 81561128020) to QZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.